The RNA Institute, in partnership with CCRM Australia and the NSW Stem Cell Network, is proud to present the The Business of Advanced Therapeutics Masterclass 2026 in the 3rd quarter of the year 2026, at the UNSW Business School, Kensington. This flagship event brings together leading experts, industry innovators, and academic thought leaders to explore the future of advanced therapeutics and their impact on global healthcare.
Designed to provide a comprehensive grounding in cutting-edge therapeutic modalities—including RNA-based therapies, gene therapies, and cell and tissue engineering—the Masterclass offers insights into the scientific, regulatory, and commercial trends shaping the sector. Join us for a keynote address on global investment in life sciences infrastructure, a curated program of expert presentations and interactive sessions, and exceptional networking opportunities within Australia’s growing advanced therapies ecosystem.
Silvio Tiziani
Catherine McDonald
Andre Serobian
Brad Eberand
Margret Schuller
Marjorie Fox-Owens
Chihwei Teng
Rachel Shparberg

CEO, Biointelect

CIO, Altea Investments

Special Council, Griffith Hack

Principal, Griffith Hack

National Business Development Manager, World Courier

Director, RNA Institute

CEO, GreenLight Clinical

Professor, Centre Director,
Westmead Hospital

Clinical Immunologist
St. Vincent’s Hospital, Director Kirby Institute, UNSW Sydney

Paediatric
Neurologist, Sydney Children's Hospital

Co-founder, EosGene Therapeutics

CEO, CCRM Australia
And more to come...
WITH THANKS TO


FOR ENQUIRIES, CONTACT LEISHMAN ASSOCIATES
227 Collins Street, Hobart, TAS 7000
P: +61 3 6234 7844
E: conference@leishman-associates.com.au